Scientists at the University of Maryland School of Medicine and Regeneron Pharmaceuticals have identified and validated two candidate therapeutics for the prevention and treatment of MERS.
MERS is caused by a virus known as MERS-Coronavirus, or MERS-CoV, and is related to the SARS (Severe Acute Respiratory Syndrome) virus. MERS is new to humans and is believed to have crossed over from camels, although other hosts, like bats, cannot be ruled out. MERS originated in Saudi Arabia in 2012 and has since spread to quite a few countries in the world. MERS is known to spread through direct contact with infected animals by eating undercooked contaminated meat, by drinking milk from infected animals, and direct human-human contact. MERS infections have a fatality rate of 40-60%. At the present time, there is a MERS epidemic in South Korea.
The need to find a cure for MERS has inspired researchers worldwide. In the study being discussed here, scientists
Professor Mathew Frieman, one of the authors in the study, is considered a leading expert on SARS, MERS and other emerging viral epidemics. Professor Frieman said to University of Maryland News, “Mice are typically not susceptible to MERS. This new mouse model will significantly boost our ability to study potential treatments and help scientists to understand how the virus causes disease in people.”
Professor Frieman, continues, “While early, this (the development of antibodies) is very exciting, and has real potential to help MERS patients. We hope that clinical study will progress on these two antibodies to see whether they can eventually be used to help humans infected with the virus.”
The obvious next step is to take the therapeutics to clinical trials. If found successful, they will mark a significant step forward in the treatment of MERS. Additionally, the success of the antibodies in prevention/treatment of MERS will prove that the techniques and knowledge gained from the study can be used to combat emerging epidemics.
Written by Mangala Sarkar Ph.D.
Primary References:
News & Events. (n.d.). Retrieved July 1, 2015, from http://somvweb.som.umaryland.edu/absolutenm/templates/?a=3123&z=41
Pascal, C.,……… Kyratsous, K. (2015). Pre- and post- exposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proceedings of the National Academy of Sciences USA.
(n.d.). Retrieved July 1, 2015, from http://www.pnas.org/content/early/2015/06/24/1510830112.full.pdf
Additional References:
(2015, June 1). Retrieved June 13, 2015, from http://www.cdc.gov/coronavirus/mers/index.html
Middle East respiratory syndrome coronavirus (MERS-CoV) – Republic of Korea. (n.d.). Retrieved June 14, 2015, from http://www.who.int/csr/don/12-june-2015-mers-korea/en/
South Korea Scrambles To Contain MERS Virus. (n.d.). Retrieved June 13, 2015, from http://www.npr.org/2015/06/09/413069579/south-korea-scrambles-to-contain-mers-virus
CDC warns U.S. doctors to watch for MERS - CNN.com. (n.d.). Retrieved June 13, 2015, from http://www.cnn.com/2015/06/11/health/cdc-us-mers/
and connect with fellow professionals
At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.
0 Comments
Please log in to post a comment.